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A B S T R A C T
Background: Cytomegalovirus (CMV) is a common pathogen affecting the gastrointestinal tract in
patients with AIDS. We report a case of CMV-induced pseudotumor of the duodenum in a patient with
AIDS and review other reported cases of CMV-induced pseudotumors in the gastrointestinal tract. CMV-
induced pseudotumor in patients with AIDS is an exceptionally rare clinical entity, and to our knowledge
no reports have previously summarized this clinical entity.
Methods: All previous cases included in our literature review were found using a PubMed search (1980–
November 2008) of the English-language medical literature applying the terms ‘CMV infection’,
‘inﬂammatory mass’, ‘pseudotumor’, and ‘gastrointestinal tract’. The references cited in these articles
were examined to identify additional reports.
Results: Although CMV-induced duodenitis has been described in patients with HIV infection, to our
knowledge CMV-induced pseudotumor of the duodenum has not been previously reported in the
literature. We describe the ﬁrst case of an AIDS patient with CMV pseudotumor responding to oral
treatment with valganciclovir with complete resolution of the CMV mass. Among reports of non-
duodenal pseudotumor reported in the English literature, we found only 14 cases of CMV-induced
gastrointestinal pseudotumors in HIV-positive patients. The clinical manifestations, pathologic ﬁndings
of the CMV pseudotumors, as well as the treatment and outcome of these HIV patients are reviewed.
Conclusion: CMV pseudotumor should be included in the differential diagnosis of gastrointestinal mass
lesions in AIDS patients and in other immunocompromised patients. The tumor often responds to
antiviral therapy, but resolution of a CMV mass as a result of oral antiviral therapy has not been
previously described. Since pseudotumors secondary to CMV often respond to medical treatment, it is
important that the physicians treating severely immunocompromised patients are aware of this entity.
 2009 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
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Cytomegalovirus (CMV) is one of the most common viral
pathogens affecting the gastrointestinal tract in patients with
AIDS. The clinical and radiographic ﬁndings of CMV esophagitis,
gastritis, enteritis, and colitis have been well documented.1,2 CMV-
induced duodenitis is rare but has been described in patients with
HIV infection.3–5 To our knowledge CMV-induced pseudotumor of
the duodenumhas not been previously reported in the literature in
this patient population. Among reports of non-duodenal pseudo-
tumor, we found only 14 cases of CMV-induced gastrointestinal
pseudotumors in HIV-positive patients reported in the English
literature (Table 1).6–15 The pseudotumors were found in the
esophagus,8,12 stomach,6,7,10,12,14 ileum,9–11,15 and colon.9–11,13,16
Since pseudotumors secondary to CMV often respond to medical* Corresponding author. Tel.: +1 617 789 3000; fax: +1 617 787 0452.
E-mail address: Theodoros.Kelesidis@caritaschristi.org (T. Kelesidis).
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doi:10.1016/j.ijid.2009.04.015treatment, it is important that the physicians treating severely
immunocompromised patients are aware of this entity. We report
a case of CMV-induced pseudotumor of the duodenum in a patient
with AIDS and review other reported cases of CMV-induced
pseudotumors in the gastrointestinal tract.
2. Case report
A 52-year-old homosexual male recently diagnosed with AIDS
after18yearsofHIV infection,onhighlyactiveantiretroviral therapy
(HAART) for the last seven years, presentedwith a one-week history
of abdominal pain associated with increased abdominal distension,
decreased oral intake, nausea, vomiting, and progressive constipa-
tion. Pastmedical history includedmultiple episodes of small bowel
obstruction of unclear etiology. Physical examination revealed an
afebrile, hemodynamically stable patient with hypoactive bowel
sounds and diffuse abdominal tenderness without any rebound
tenderness or guarding. Pertinent laboratory data included a white
blood cell count of 8.9  109/l with a normal metabolic panel, liverses. Published by Elsevier Ltd. All rights reserved.
Table 1
Cases of cytomegalovirus pseudotumor of the gastrointestinal tract in patients with HIV infection
Author (year) [Ref.] Location Age Sex HIV status/ART Clinical picture Method of diagnosis Characteristics of pseudotumor Outcome Treatment
Victoria (1985)6 Stomach,
pylorus
16 months M A child with AIDS Pyloric
obstruction with
nausea,
vomiting, fever
Open biopsy from
stomach and
duodenum.
Postmortem
examination
Occlusion of the pylorus with
thickening of the walls. CMV
inclusion bodies on the glandular
epithelium and muscle layer of
pylorus with extensive
inﬂammatory inﬁltration
The patient died in his
hospital course of
progressive respiratory
failure
Not described
Elta (1986)7 Stomach
(gastric antrum)
29 years M Homosexual
transmission. AIDS
with CD4/CD8 ratio of
0.36
Abdominal pain,
watery diarrhea
and fever. Non-
obstructive
prepyloric mass
Submucosal mass was
identiﬁed in CT
abdomen and upper
endoscopy. Open
biopsy after
exploratory
laparoscopy
Irregular mass, mucosal sparing,
marked inﬂammation. Inﬁltrate of
predominantly mononuclear cells,
edema, and numerous stromal and
epithelium cells with CMV inclusion
bodies
Patient died 2 months
later after diagnosis of
CMV infection
Surgery. No
information was
provided about
medical
treatment
Dolgin (1990)15 Small bowel Infant M Infant with AIDS Enteritis
presenting with
massive
hemorrhage and
subsequent fatal
small bowel
obstruction
Laparotomy.
Postmortem
examination
Striking, diffuse, large yellowish
plaques along the entire length of
the small bowel. Each of these had a
central ulceration. Each eventually
caused a partial narrowing resulting
in refractory small bowel
obstruction. Biopsy of one of these
lesions demonstrated many cells
with typical cytomegalic inclusion
bodies
Patient died of
bleeding and small
bowel obstruction
Surgery
Wilcox (1990)8 Esophagus NR NR AIDS for 8 months Epigastric pain
for 6 months
Endoscopy Exophytic mass. Characteristic
inclusion bodies mostly in
endothelial cells and in ﬁbroblasts,
epithelial cells
Could not be evaluated
by authors. Patient
died after 4 months
Ganciclovir
Duva-Frissora (1991)9 Cecum, ileum 36 years M AIDS. No other data
speciﬁed
One month
watery diarrhea
and fevers, CT
ﬁnding
Open biopsy after right
side ileocolectomy
Pericolonic mass with adenopathy,
mucosal sparing, inﬂammation.
Pathologic examination revealed a
cytomegalovirus-mediated
inﬂammatory pseudotumor within
the muscularis and submucosa with
complete mucosal sparing
NR Surgery. No
information was
provided about
medical
treatment
Rich (1992)10 Stomach
(gastric fundus)
41 years M Homosexual
transmission. HIV
seropositivity 5 years
prior to diagnosis of
AIDS. Other
opportunistic infection
prior to CMV infection
were cerebral
toxoplasmosis
Epigastric mass,
LUQ palpable
mass
Endoscopy. Serology
positive for CMV
Polypoid 5-cm wide necrotic mass
with ulceration, necrosis, ﬁbrosis.
Cytomegalic change was present
within glandular epithelial cells,
which stained positive for CMV with
immunoperoxidase
His gastrointestinal
symptoms completely
resolved following
treatment
Ganciclovir
Rich (1992)10 Cecum 41 years M Homosexual
transmission. HIV
seropositivity 3 years
prior to diagnosis of
AIDS
Abdominal pain
w/o diarrhea
Colonoscopy. Excision
biopsy (right
colectomy)
Focal polypoid friable, ﬁrm near
circumferential mass with
ulceration, ﬁbrosis. Microscopic
examination revealed granulation
tissue in the ulcer bed, overlying
acute inﬂammatory exudate, CMV
like inclusions identiﬁed in
endothelial cells and ﬁbroblasts
within the granulation tissue.
Presence of CMV was conﬁrmed by
immunoperoxidase staining
The patient’s pain was
completely resolved
following surgery and
did not recur
Surgery,
ganciclovir
T
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Author (year) [Ref.] Location Age Sex HIV status/ART Clinical picture Method of diagnosis Characteristics of pseudotumor Outcome Treatment
Rich (1992)10 Cecum (primary
mass), ileum
(recurrence)
34 years M Homosexual
transmission. AIDS
diagnosed 1 year prior
to presentation. Other
opportunistic infection
prior to CMV infection
was cerebral
toxoplasmosis
Abdominal pain
w/o diarrhea,
fever (primary
mass).
Recurrence of
abdominal pain
(relapse)
Colonoscopy. Excision
biopsy (right
colectomy)
4 cm polypoid mass with ulceration,
necrosis, ﬁbrosis (primary mass and
relapse). Microscopic examination
revealed extensive ﬁbrosis,
granulation tissue and chronic
inﬂammation. Numerous CMV like
inclusions identiﬁed in
mesenchymal cells and were
conﬁrmed by immunoperoxidase
staining. Relapse mass was a 2 cm
inﬂammatory polyp with similar to
the previous mass microscopic
ﬁndings
The abdominal pain
resolved after surgery.
One year later he
developed relapse,
which was again
successfully treated
with ganciclovir and
surgery
Surgery for
primary mass.
Surgery and
ganciclovir for
recurrent mass
Wisser (1992)11 Cecum/
terminal
ileum
36 years M Homosexual
transmission. AIDS
diagnosed 1 year prior
to admission.
Zidovudine alone for a
year
Generalized
abdominal pain,
bloody diarrhea,
night sweats, 1
month h/o
tenesmus, 40 lb
weight loss
Excision biopsy after
right colectomy
Size: 6  5.3  5.1 cm, irregular
exophytic mass. Histology showed
necrosis and ﬁbrosis, particularly in
the muscularis propia, as well as
ﬁbroblastic and vascular
proliferation with pleomorphic and
mononuclear cell inﬁltrates. CMV
inclusion bodies were present in
endothelial cells, ﬁbroblasts, muscle,
ganglion cells. In situ hybridization
conﬁrmed CMV inclusions
Patient died 12 days
postoperatively from
bacterial sepsis
Surgery. No
medical
treatment
reported
Laguna (1993)12 Stomach
(gastric
antrum)
42 years M Homosexual
transmission. AIDS
diagnosed 1 year prior
to admission. On
zidovudine. Other
opportunistic infection
prior to CMV infection
was PCP
Epigastric pain Endoscopy CMV was
cultured in urine
Large rigid folds in the stomach
without ulcers. Characteristic large
intranuclear inclusions were
identiﬁed on routine hematoxylin
and eosin staining of esophageal and
gastric biopsies
3 days after treatment
with ganciclovir he
developed a psychotic
syndrome and
treatment was
changed to foscarnet.
Patient improved after
3 weeks of treatment
Ganciclovir,
foscarnet
Laguna (1993)12 Esophagus 40 years M Homosexual
transmission. AIDS
diagnosed 14 months
prior to admission. On
zidovudine. Other
opportunistic infection
prior to CMV infection
was PCP
Epigastric pain,
fever
Endoscopy Polypoid, exophytic mass without
ulceration in the distal esophagus.
Immunohistochemical staining with
a CMVmonoclonal antibody showed
intranuclear inclusions in the
esophagus biopsies
After 3 weeks of
treatment he remained
febrile but abdominal
pain had improved.
Patient died 12 days
after cardiac arrest
Ganciclovir (6
weeks),
foscarnet (2
weeks)
Swansiger (1996)16 Colon 28 years M Homosexual
transmission. HIV
infection diagnosed 7
years before
presentation. Patient
was on zidovudine
RLQ abdominal
pain of 1-year
duration.
Weight loss,
intermittent
fever and chills
Biopsies obtained at
ﬁrst colonoscopy
showed intranuclear
inclusion bodies, but
viral culture was
negative. Cultures of
biopsies obtained at
repeat colonoscopy
after 4 months grew
CMV
Multilobulated intraluminal mass
with an overall length of 4.5 cm.
Biopsies from repeat colonoscopy
showed chronic inﬂammation with
vascular endothelial thickening, and
culture of the biopsy grew CMV
NR 5 mg/kg
ganciclovir
given IV every
12 h
T
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Figure 1. Endoscopic view of the inﬂammatory mass seen in the duodenum (on the
left side).
T. Kelesidis et al. / International Journal of Infectious Diseases 14 (2010) e274–e282 e277function tests, as well as amylase and lipase. He had a plasma HIV
RNA level of <50 copies/ml and a recent CD4 count of 79 cells/ml.
CMV was not detected by PCR in the blood. Serology for CMV
revealed positive IgM anti-CMV and IgG anti-CMV. A computed
tomography (CT) of the abdomen revealed a distal small bowel
obstruction. An endoscopic study revealed esophagitis, duodenitis,
and a large mass in the duodenal bulb causing luminal narrowing,
which prevented passing the endoscope into the second part of the
duodenum (Figure 1). No bleeding or ulcers were found. Histologic
examination ofmultiple biopsies from themass revealed cytopathic
changes compatible with CMV (Figure 2). More speciﬁcally, marked
acute and chronic inﬂammation in the mucosa and submucosa was
found with endothelial cell atypia suggestive of viral cytopathic
effect. Similar ﬁndings have been reported in other CMV-induced
pseudotumors (Table 1). Immunohistochemical staining using a
CMV monoclonal antibody (Dako CCH2/DDG9) against CMV early
antigen was positive (Figure 3). Stains for other microorganisms
(acid-fast bacillus, Gomorimethenamine silver, periodic acid-Schiff)
and for other viral pathogens (herpes simplex virus, adenovirus)
were negative. The patient’s symptoms improved after hydration
and bowel rest and hewas discharged after six days. Hewas treated
with oral valganciclovir (900 mg twice daily) for ﬁve weeks. Before
the diagnosis of the CMV-induced pseudotumor the patient was on
an antiretroviral regimen that included abacavir, lamivudine, and
zidovudine. However, a genotype analysis of the virus revealed
resistance of the virus to all nucleoside reverse transcriptase
inhibitors (NRTIs). Thus, the antiretroviral regimen was changed to
efavirenz, lopinavir, ritonavir, and tenofovir DF (tenofovir was usedFigure 2. Vascular proliferation at the periphery of the inﬂammatory mass with
viral cytopathic effect in endothelial cells (H&E  400).
Figure 3. Cytomegalovirus (CMV) intranuclear inclusions in endothelial cells and epithelial cells of duodenal crypts. Immunohistochemical staining using a CMVmonoclonal
antibody (Dako CCH2/DDG9) against CMV early antigen was positive (400).
T. Kelesidis et al. / International Journal of Infectious Diseases 14 (2010) e274–e282e278for the treatmentof co-infectionwithhepatitisBvirus). TheHIVRNA
levels remained <50 copies/ml during all this period and the CD4
count slowly increased. A repeat endoscopy after sixweeks revealed
persistentmass in theduodenumwithslightdecrease in size. Repeat
biopsies were negative for CMV. One year later an endoscopy
conﬁrmed resolution of themass and at that time the CD4countwas
179 cells/ml.
3. Discussion
CMV infection of the alimentary tract is common in immuno-
compromised patients, including patients with AIDS.2,17,18 The
infection may affect any part of the gastrointestinal tract from the
esophagus to the rectum, either by diffuse or isolated involvement.
It can produce perforation or present subclinically as an incidental
pathologic ﬁnding with or without any associated opportunistic
pathogens. It may also involve the pancreas, gallbladder, and
liver.19,20
CMV involvement of the duodenum is a rare entity. Isolated
CMV duodenitis has been described in patients with HIV
infection.3,4 Inﬂammation of the ampulla of Vater secondary to
CMV infection has been reported,5,21 but usually in association
with AIDS and cholangiopathy.22 As in patients with CMV
involving other portions of the gastrointestinal tract, patients
with CMV duodenitis are at risk for developing complications such
as bleeding, perforation, and peritonitis. Early treatment with
appropriate antiviral agents may be essential before these
complications ensue. However, the clinical entity of CMV-
associated gastrointestinal pseudotumors has not been reviewed
previously and we summarize the available scientiﬁc evidence for
the ﬁrst time, to our knowledge.
4. Literature review
4.1. Search strategy and selection criteria
All previous cases included in our literature review were found
using a PubMed search (1980–November 2008) of the English-
language medical literature applying the terms ‘CMV infection’,
‘inﬂammatory mass’, ‘pseudotumor’, and ‘gastrointestinal tract’.The references cited in these articles were examined to identify
additional reports.
4.2. Results
Our review of the literature yielded a total of 25 caseswith CMV-
associated gastrointestinal pseudotumors, 14 of which were AIDS
patients (Table 1)6–15 and 11 non-HIV patients (Table 2), including
ﬁve immunocompetent patients,21,23,24 four patients after organ
transplantation,25–28 one patient with common variable immuno-
deﬁciency syndrome,29 and one patientwith chronic renal failure.30
The distribution of pseudotumors in the gastrointestinal tract
seems to parallel the predilection of CMV for the esophagus and
right colon/ileocecal area.10 In our review of 14 cases, the colon
was the most commonly involved area (42.9% of cases),9–11,13,16
followed by the antrum of the stomach (21.4% of cases),7,12,14 the
esophagus (14.3% of cases),8,12 the gastric fundus (7.1% of cases),10
and the gastric pylorus (7.1% of cases).6 Isolated small-bowel
involvement with CMV was noticed in one case.15
Most of the reports of AIDS patients who developed gastro-
intestinal CMV pseudotumor acquired HIV infection through
homosexual transmission, similar to our case (8/12).7,10–12,16 In
three cases opportunistic infections had developed prior to CMV
infection,10,12 whereas in two cases there was co-infection in the
lesion with cryptosporidia14 andMycobacterium avium complex.12
4.3. Pathogenesis of CMV pseudotumor
The pathogenesis of CMV pseudotumor remains unclear. The
thickening of the bowel wall in patients with CMV is thought to be
caused histologically by submucosal edema, granulation tissue,
and ﬁbrosis.31 More speciﬁcally, the histologic characteristics of
the pseudotumor include inﬂammatory inﬁltration in the mucosa
and submucosa, characteristic inclusion bodies mostly in endothe-
lial cells, ﬁbroblasts and epithelial cells, with associated extensive
ﬁbrosis, granulation tissue, and chronic inﬂammation (Table 1).
These changes may result in a gastrointestinal inﬂammatory mass
capable of causing bowel obstruction and mimicking exophytic
neoplastic luminalmass lesions on barium studies, endoscopy, and
CT scans.
T. Kelesidis et al. / International Journal of Infectious Diseases 14 (2010) e274–e282 e279Some authors propose that CMV is a secondary superinfection
of previously damaged tissues.21 Except for a few cases, informa-
tion regarding the duration of AIDS, concurrent opportunistic
infections and malignancies, response to therapy, and survival
were not available from the reports of CMV-induced pseudotumors
reviewed herein. Interestingly, other pathogens (cryptosporidia,
mycobacteria) were also detected in the inﬂammatory pseudotu-
mor in two cases.12,14 Thus it remains unclear if these pathogens
are superinfection to an inﬂammatory process that has already
been initiated by an unknown mechanism. Other authors believe
that CMV is a primary enteric pathogen since CMV has been
detected with immunohistochemistry in certain cells.13,21 In all
reported cases reviewed herein, documentation of CMV infection
was done either by typical inclusion bodies seen histologically or
by immunohistological staining. CMV most commonly infects
mesenchymal cells and tends to target endothelial cells, while
glandular or surface epithelium cells are infrequently affected.25,32
In one case, culture of the biopsy from a pseudotumor grew CMV.16
Although epithelial cell involvement often lacks an inﬂammatory
reaction, mesenchymal cell involvement is often accompanied by
patchy nonspeciﬁc inﬁltration of acute and chronic inﬂammatory
cells. Exuberant formation of granulation tissue and inﬂammation
in response to CMV could theoretically be responsible for
formation of a CMV-induced inﬂammatory mass or pseudotumor.
Consistent with this theory is our ﬁnding that in all the cases of
CMV-induced pseudotumors described in the literature in patients
with AIDS, the predominant cells where CMV inclusions were
identiﬁed were stromal and epithelium cells, whereas in CMV-
induced ulcerations the predominant cells involved are usually
endothelial cells (Table 1).
Autopsy ﬁndings on CMV-associated gastrointestinal masses in
simian immunodeﬁciency virus (SIV)-infected macaques33
revealed that histologically the masses were composed of
hyperplastic glandular tissue, dense neutrophilic inﬁltrates within
the lamina propia, and frequent cytomegalic cells with intra-
nuclear inclusions in affected regions. Immunohistochemistry
demonstrated frequent CMV immunopositive cells within affected
areas. Furthermore, immunohistochemistry for the proliferation
marker Ki-67 demonstrated increased proliferation in hyperplastic
glands and crypts.33 The authors in this study concluded that CMV
should be considered a cause of discrete mass lesions in the
gastrointestinal tract of SIV-infected macaques.33
In the cases listed above it is not possible to establish whether
the CMV infection occurred as a primary event or as a reactivation,
partly due to limitations of serological studies in immunocom-
promised patients and partly since serological studies were not
performed in most of the described cases. However, since the
frequency of CMV reactivation has been shown to increase linearly
with age because of the decline of immunity,34 the occurrence of
large intestinal inﬂammatory pseudotumors might represent an
advanced stage of a previously unidentiﬁed CMV infection.11
Further studies are needed to elucidate the pathogenesis of CMV-
induced pseudotumors.
4.4. Clinical manifestations
CMV infection of the bowel typically presents as enterocolitis,
with chronic diarrhea, fever, abdominal pain, weight loss, melena,
and hematochezia.1 Perforations, massive hemorrhage, and toxic
megacolon have also been reported.35,36
The most common clinical symptom of CMV-induced gastro-
intestinal pseudotumors in patients with AIDS was abdominal
pain, which was present in 71.4% of cases in our series.7,8,10–14,16
Fever,6,7,9,10,12,16 change of bowel habits,7,9,11,13,14 and weight
loss11,13,14,16 were present in 42.9% (6/14), 35.7% (5/14) , and 28.6%
of the cases, respectively, and a palpable mass was present in onecase.10 CMV pseudotumor presented as a non-obstructing mass in
78.6% of the cases, as a small bowel obstruction in 14.2% (2/14) of
cases,11,15 and in 7.1% (1/14) it presented as obstruction of the
gastric pylorus.6 In two cases the CMV pseudotumor was
diagnosed in the setting of gastrointestinal bleeding.11,15
4.5. Diagnostic methods
Routine hematoxylin and eosin staining of biopsy specimens
supplemented by immunohistochemical stains is the diagnostic
method of choice and was done in all the cases reviewed herein,
including our case. From a review of 14 reported cases of CMV-
induced gastrointestinal pseudotumors in HIV-positive patients,
serologywas used for diagnosis of CMV infection in only one case.10
We could not ﬁnd any data on the use of PCR or detection of CMV
antigen in these cases. Thus, although serum analysis is a
widespread method for the diagnosis of CMV infection, it has not
been used widely as a tool for the diagnosis of CMV-induced
pseudotumors. The fact that PCR of the blood in our case was
negative for CMV could represent a more indolent chronic CMV
infection at the tissue level,whichmaynot necessarily be associated
withCMVviremia. Positive PCR for CMVdoesnot always translate to
end-organ involvement in HIV patients, and histology is the gold
standard for the diagnosis of end-organ involvement of CMV
infection in this group of patients. Viral culture for CMV is unreliable
and may be positive in the absence of invasive CMV disease. Of the
cases reviewed it was only available in two cases.12,16 More
experience is clearly needed regarding the use of conventional
methods of diagnosis of CMV infection such as PCR and serologic
studies in cases of CMV-induced pseudotumors in HIV patients.
4.6. Treatment
Treatment of CMV infection of the gastrointestinal tract is well
established and usually includes treatment with ganciclovir,2
however data regarding the treatment of CMV-induced pseudo-
tumors are sparse. Of the 14 AIDS cases reviewed, ﬁve patients
were treated medically with ganciclovir;8,10,12,16 in two of those
cases the patients were treated with both surgery and ganciclo-
vir.10 Two additional cases were initially treated with ganciclovir
but treatment was changed to foscarnet due to side effects.12 No
information with regards to medical treatment was given in the
remainder of the reviewed cases. The CMV-induced pseudotumor
often responds to antiviral therapy but only intravenous antiviral
therapy has been described.8,10,12,16We describe the ﬁrst case of an
AIDS patient with CMV pseudotumor responding to oral treatment
with valganciclovir with complete resolution of the CMVmass. The
increasing CD4 count most likely contributed signiﬁcantly to the
resolution of the CMV mass, but it is difﬁcult to determine in vivo
the relative contribution of oral valganciclovir versus the immune
reconstitution effect in the resolution of the CMV mass. A repeat
endoscopy one week after completion of antiviral treatment
revealed slight reduction in the size of the mass. Given the lack of
data regarding the natural history of CMV pseudotumors it is
difﬁcult to assess if the reduced size was a treatment effect or a
response to immune reconstitution.
A diagnostic surgical approach was performed in eight cases
(57.1%),7,9–11,13–15 while for one case no data on treatment were
available.6 Operative intervention was elective in all but two
patients, in whom emergency surgerywas necessary for bowel and
pyloric outlet obstructions.6,11 Both of these patients died as a
result of postoperative complications (Table 1).
The duration of treatment in HIV-positive patients varied from
3 weeks in one case12 to 8 weeks in another case (6 weeks of
ganciclovir and 2 weeks of foscarnet),12 while the treatment
duration was not reported in three cases.8,10,16
Table 2
Cytomegalovirus pseudotumors of the gastrointestinal tract in patients without HIV infection
Author
(year) [Ref.]
Location Age Sex Immunocompromised
status
Clinical picture Method of
diagnosis
Characteristics of pseudotumor Outcome Treatment
Garcia
(1987)23
Stomach
antral area
44 M No history of
immunosuppression
except concurrent
heterophil-negative
mononucleosis; the
HIV status was not
reported
Fever, abdominal pain Endoscopy.
Positive
serology for
CMV
Rigid narrowed gastric antrum and a
deformed duodenal bulb suggestive of
antral neoplasia. Histologic
examination revealed ulcerated gastric
mucosa and CMV inclusions in
endothelial cells, macrophages, and rare
epithelial cells
The pseudotumor
remitted
spontaneously and
showed radiographic
improvement without
surgery or antiviral
therapy
No speciﬁc treatment
Roberts (1989)25 Esophagus NR NR Patient with a renal
transplant; no other
information was given
NR NR CMV-positive cells in a biopsy specimen
of an esophageal mass
NR NR
Lewis-Jones
(1990)26
Colon 53 M Renal transplantation
on maintenance
immunosuppression
(azathioprine and
prednisolone)
Masquerading as
colonic neoplasia:
epigastric pain and
diarrhea for 2 months
Barium enema.
Surgery
(excision
biopsy)
5 cm long eccentric stricture involving
the proximal transverse colon with
mucosal irregularity and ulceration.
Histology of a 4  2 cm ulcer revealed
multiple nuclear and cellular inclusions
characteristic of CMV with normal
mucosa and no signs of malignancy
NR Surgery
Cheung
(1993)21
Duodenum
(ampulla of
Vater) (2 cases)
NR NR Non-immunocompromised
patients
Obstructive
jaundice
Endoscopy Obstructive jaundice as a result of
exuberant formation of granulation
tissue, ﬁbrosis, inﬂammation at the
ampulla of Vater, resembling
malignancy and resulting in bile ﬂow
obstruction. Histologic identiﬁcation of
CMV inclusion bodies and positive
immunohistochemical staining with
anti-CMV antibodies
NR NR
Falagas
(1996)30
Colon 57 M Chronic renal failure Abdominal pain,
bloody diarrhea,
fever
Colonoscopy.
Exploratory
laparotomy
Large polypoid mass at the hepatic
ﬂexure of colon. Large cell with
intranuclear inclusions and submucosal
ﬁbrosis
Symptoms resolved
after 2 weeks of
treatment
Ganciclovir for 2 weeks
Shrestha
(1996)37
Colon. Not a
true mass
just pseudo-
obstruction
(Ogilvie)
69 F 10 weeks post renal
transplantation
Acute colonic
pseudo-obstruction
with symptoms of
abdominal pain,
diarrhea, fever,
weight loss
Sigmoidoscopy.
Positive CMV
antigenemia and
anti-CMV IgM
Inﬂamed rectum and sigmoid colon.
Biopsy showed intranuclear inclusions
NR Ganciclovir
Diaz-Gonzalez
(1997)27
Colon (mid-
transverse
colon)
57 F 14 months after heart
transplantation on
cyclosporine, azathioprine
Abdominal pain,
diarrhea, fever
CT. Colonoscopy.
Right
hemicolectomy
Thickening of the colon surrounding the
base of ulcer in mid transverse colon,
which lead to formation of stricture. The
pathologic specimen showed CMV
inclusion bodies with acute suppurative
ulceration
At 14months of follow-
up the patient had no
evidence of rejection or
CMV infection
Surgery. Ganciclovir for
2 weeks after surgery
Crespo
(1998)28
Colon
(descending
colon)
62 M Heart transplantation on
cyclosporine, azathioprine
and prednisone
Abdominal pain,
constipation, and
hematochezia of
12 h in duration
Colonoscopy.
Barium enema.
Left colectomy
Colonoscopy revealed a friable, 6 cm
stenosing lesion in the left colon and
endoscopic biopsies revealed deep
ulcers with frequent ﬁbrin thrombi,
large ﬁbroblasts, and endothelial cells
with the intranuclear inclusions typical
of CMV infection.
Immunohistochemical staining with
anti-CMV antibodies was positive
Patient underwent left
colectomy but had
persistent symptoms
and he underwent a
repeat colonoscopy. He
was placed on
foscarnet and his
subsequent course was
satisfactory
The patient was treated with a
4-week course of intravenous
ganciclovir and hyperimmune
anti-CMV globulin for 1 week.
After surgery the patient was
again treated with intravenous
ganciclovir for 3 weeks. Due to
persistent symptoms, resistance
to ganciclovir was suspected, and
the patient was treated for 3
weeks with foscarnet (60 mg/kg
every 8 h)
T
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T. Kelesidis et al. / International Journal of Infectious Diseases 14 (2010) e274–e282 e281Of the 11 non-HIV patients who developed CMV-induced
gastrointestinal pseudotumor, ganciclovir was given to three
patients,29,30,37 surgery was performed in one case,26 while in four
cases the patients were treated with both surgery and ganciclo-
vir.24,24,27,28 Data on treatment were not reported in three cases
(Table 2).21,23,25 In patients without HIV infection the duration of
medical treatment varied from 2 to 8 weeks.29 Information
regarding the duration of AIDS, concurrent opportunistic infec-
tions, HAART therapy, and associated malignancies, or response
to therapy and survival was not consistently available for
comparison.6,8,9
4.7. Outcomes
HIV patients with CMVmasses have a grim prognosis, and poor
outcome (death or relapse) was documented in 63% of the cases
with available data.6–8,11,12,14,15 In one case, similar to our case,
symptoms abated and the focal mass appeared to resolve
endoscopically following treatment with ganciclovir alone.10 Thus,
in our opinion, and based on the sparse available data, surgical
intervention should be reserved for patients whose lesions fail to
respond to medical therapy alone or those who present with a
surgical indication such as outlet obstruction.
Recurrence of the CMV pseudotumors was noted at the
anastomic site in one patient who required a second laparotomy
for resection of the recurrent mass 14 months after the original
resection.10 Only one case of gastric pseudotumor in an
immunocompetent patient remitted spontaneously and showed
radiographic improvement without surgery or antiviral therapy.23
No deaths were reported in the non-AIDS patients.
5. Conclusions
Although CMV has been described to involve any part of the
gastrointestinal tract, localization to the small bowel and
especially the duodenum is rare. We have described, to our
knowledge, the ﬁrst case report of isolated CMV-induced mass in
the duodenum of a patient with AIDS. As the length of survival of
patients with AIDS increases, CMV pseudotumors are not likely to
remain unique. CMV pseudotumor should be included in the
differential diagnosis of gastrointestinal mass lesions in AIDS
patients and in other immunocompromised patients. The tumor
often responds to antiviral therapy.8,10,12,16 We have described the
ﬁrst case of an AIDS patient with CMV pseudotumor responding to
oral treatment with valganciclovir with complete resolution of the
CMV mass. The role of surgery as treatment for a CMV-induced
mass has not been clearly deﬁned. It is hard to know what the role
of immune reconstitution would be in this group of patients, and if
resolution of the pseudotumor may be achievable by HAART
therapy alone. Larger studies are needed to further study this
entity and to outline treatment guidelines.
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